Kane Biotech Inc. announced that it has published strong positive results from a recent consumer trial of its DermaKB™ products. Kane Biotech recently published on its website the results of a significant consumer trial which began in November, 2020 and ended in January, 2021. Over 4500 participants signed up for the trial, with 1,402 filling out and submitting the questionnaire. Overall, the results were compelling with an average of 82% of participants seeing an improvement in their symptoms using both the Detoxifier and the Shampoo, with an average 33% reduction in the severity of symptoms after using only a three oz. sample of either product. Results of the trial are also available on the DermaKB™ website. Achieving these results after using such a small amount of sample product is very compelling. Even more remarkable is the result that of those participants who identified the leading dandruff shampoo as their most often used shampoo prior to the trial, 63% said they preferred DermaKB™ products, either individually or combined after the trial.